Dover has entered into a definitive agreement to acquire Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management instruments for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will expand Dover’s biopharma single-use production offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue during the full yr 2022.
When the deal closes, Malema will become part of the PSG business unit inside Dover’s Pumps & Process Solutions phase.
“We see an incredible long-term growth alternative in the bioprocessing trade driven by a powerful and rising pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of more environment friendly single-use production processes supports a strong outlook for our offerings of single-use components to end-customers. We consider that pairing Malema’s know-how with our current portfolio of single-use pumps for biopharma processing will greatly enhance the accuracy and value proposition of our options to our prospects.”
“ ที่วัดแรงดัน are methodically constructing out our biopharma platform through proactive capacity additions, new product development, and opportunistic acquisitions of highly-attractive area of interest component applied sciences,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and additional strengthens our sensor portfolio with new proprietary expertise. In addition to engaging biopharma purposes, we count on strong development in the semiconductor house on the capacity growth and re-shoring tailwinds.”
Share